The inhaler - by which a spray deposits insulin directly into the lungs - is being tested in the UK after successful experiments in Canada. The spray could be a lifesaver for thousands of ...

A law signed in 2023 caps out-of-pocket costs for insulin, asthma inhalers, and epinephrine injectors beginning Jan. 1.

Currently indicated to improve glycemic control in adults with diabetes, the company announced 6-month results from its Phase 3 INHALE-1 study of inhaled human insulin in children and adolescents ...

“We are excited for Cipla to market the first inhaled insulin treatment option for adults living with diabetes in India and expect to prepare product for export by the end of 2025.” MannKind ...

Dec. 16, 2024 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products and devices for patients with ...

An “inhaled insulin” is set to join the repertoire of options available to people with diabetes, as drugmaker Cipla completes last mile procedures to import Afrezza from US’ MannKind ...